Trial intelligence / Profile preview

Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery

NCT03280745Phase 4Completed

Sponsor
Insel Gruppe
Start
Feb 2018
Primary completion
May 2019
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of hypertonic saline in ischemic heart disease (IHD), valvular heart disease (VHD), sponsored by Insel Gruppe. Started Feb 2018; status: completed.

02

Drugs

hypertonic saline
03

Conditions

ischemic heart disease (IHD)valvular heart disease (VHD)

Beyond the preview

Go deeper on NCT03280745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03280745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call